Literature DB >> 25463090

Extracellular pyrophosphate is reduced in aortic interstitial valve cells acquiring a calcifying profile: implications for aortic valve calcification.

Marcello Rattazzi1, Elisa Bertacco2, Laura Iop3, Susanna D'Andrea2, Massimo Puato2, Giacomo Buso2, Valerio Causin4, Gino Gerosa3, Elisabetta Faggin2, Paolo Pauletto5.   

Abstract

OBJECTIVES: Pyrophosphate (PPi) is a potent inhibitor of ectopic mineralization but its role during aortic valve calcification is not known.
METHODS: Anti-calcific effect of PPi was investigated by using an in vitro model of serum-driven calcification of collagen sponges and decellularized porcine aortic valve leaflets. Bovine interstitial valve cells (VIC), seeded either within the collagen matrices or in transwell chambers, were used to test cellular ability to inhibit serum-induced calcification. PPi metabolism was investigated in clonal VIC harboring different calcifying potential.
RESULTS: In a cell-free system, high serum levels induced a dose-dependent calcification of type I collagen matrices which was prevented by PPi and ATP supplementation. Blockade of serum-driven calcification by PPi and ATP was also observed when using decellularized porcine aortic valve leaflets. A similar anti-calcific effect was also seen for bovine VIC, either statically seeded into the collagen matrices or co-cultured by using a transwell system. However, when we performed co-culture experiments by using clonal VIC harboring different calcifying potential, we observed that the subset of cells acquiring a pro-calcific profile lost the ability to protect the collagen from serum-driven calcification. Pro-calcific differentiation of the clonal VIC was accompanied by increase in ALP along with significant reduction in NPP activity and ATP/PPi extracellular accumulation. These changes were not observed in the clonal subtype with lower propensity towards calcification.
CONCLUSIONS: We showed that PPi and ATP are potent inhibitors of serum-driven calcification of collagen matrix and that their extracellular accumulation is reduced in calcifying VIC.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ATP; Aortic stenosis; Aortic valve calcification; Interstitial valve cells; Pyrophosphate

Mesh:

Substances:

Year:  2014        PMID: 25463090     DOI: 10.1016/j.atherosclerosis.2014.10.027

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  14 in total

Review 1.  Mineral metabolism and cardiovascular disease in CKD.

Authors:  Hideki Fujii; Nobuhiko Joki
Journal:  Clin Exp Nephrol       Date:  2017-01-06       Impact factor: 2.801

2.  Preoperative hypomagnesemia as a possible predictive factor for postoperative increase of transvalvular pressure gradient in hemodialysis patients treated with transcatheter aortic valve implantation.

Authors:  Satoshi Masuyama; Masayuki Mizui; Koichi Maeda; Kazuo Shimamura; Yusuke Sakaguchi; Masashi Morita; Toru Kuratani; Isamu Mizote; Daisuke Nakamura; Yasushi Sakata; Yoshiki Sawa; Shigeru Miyagawa; Yoshitaka Isaka
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

Review 3.  Inorganic Pyrophosphate Deficiency Syndromes and Potential Treatments for Pathologic Tissue Calcification.

Authors:  Douglas Ralph; Koen van de Wetering; Jouni Uitto; Qiaoli Li
Journal:  Am J Pathol       Date:  2022-02-16       Impact factor: 5.770

Review 4.  Calcific aortic stenosis.

Authors:  Brian R Lindman; Marie-Annick Clavel; Patrick Mathieu; Bernard Iung; Patrizio Lancellotti; Catherine M Otto; Philippe Pibarot
Journal:  Nat Rev Dis Primers       Date:  2016-03-03       Impact factor: 52.329

5.  RANKL Expression Is Increased in Circulating Mononuclear Cells of Patients with Calcific Aortic Stenosis.

Authors:  Marcello Rattazzi; Elisabetta Faggin; Elisa Bertacco; Roberta Buso; Massimo Puato; Mario Plebani; Martina Zaninotto; Davide Condotta; Giacomo Zoppellaro; Leopoldo Pagliani; Giuseppe Tarantini; Sabino Iliceto; Elisa Covolo; Giuseppe Faggian; Francesco Onorati; Mikhail Dodonov; Alessandro Daniotti; Paola Pantano; Zoran Olivari; Giovanni Benfari; Paolo Pauletto
Journal:  J Cardiovasc Transl Res       Date:  2018-05-17       Impact factor: 4.132

Review 6.  Review: Unmet Needs and the Path Forward in Joint Disease Associated With Calcium Pyrophosphate Crystal Deposition.

Authors:  Abhishek Abhishek; Tuhina Neogi; Hyon Choi; Michael Doherty; Ann K Rosenthal; Robert Terkeltaub
Journal:  Arthritis Rheumatol       Date:  2018-06-14       Impact factor: 10.995

7.  Ectopic calcification in pseudoxanthoma elasticum responds to inhibition of tissue-nonspecific alkaline phosphatase.

Authors:  Shira G Ziegler; Carlos R Ferreira; Elena Gallo MacFarlane; Ryan C Riddle; Ryan E Tomlinson; Emily Y Chew; Ludovic Martin; Chen-Ting Ma; Eduard Sergienko; Anthony B Pinkerton; José Luis Millán; William A Gahl; Harry C Dietz
Journal:  Sci Transl Med       Date:  2017-06-07       Impact factor: 17.956

Review 8.  Role of oxidative stress in calcific aortic valve disease and its therapeutic implications.

Authors:  Harry Z E Greenberg; Guoan Zhao; Ajay M Shah; Min Zhang
Journal:  Cardiovasc Res       Date:  2022-05-06       Impact factor: 13.081

9.  Exploiting novel valve interstitial cell lines to study calcific aortic valve disease.

Authors:  Hiu-Gwen Tsang; Lin Cui; Colin Farquharson; Brendan M Corcoran; Kim M Summers; Vicky E Macrae
Journal:  Mol Med Rep       Date:  2017-11-27       Impact factor: 2.952

10.  Inorganic pyrophosphate is reduced in patients with systemic sclerosis.

Authors:  Vivien M Hsu; Eszter Kozák; Qiaoli Li; Márta Bocskai; Naomi Schlesinger; Ann Rosenthal; Scott T McClure; László Kovács; László Bálint; Szilvia Szamosi; Gabriella Szücs; Mary Carns; Kathleen Aren; Isaac Goldberg; András Váradi; John Varga
Journal:  Rheumatology (Oxford)       Date:  2022-03-02       Impact factor: 7.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.